Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noliglutide Injection in Type 2 Diabetes Mellitus
CTR20190235Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of noliglutide in type 2 diabetes mellitus (T2DM), sponsored by Hengrui Therapeutics. Started Feb 2019; status: completed.
02
Drugs
noliglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20190235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190235.